Sandra De Meyer

Telaprevir for Retreatment of HCV Infection

Stefan Zeuzem, Pietro Andreoné, Stanislas Pol et al. · New England Journal of Medicine · 2011 · 1.5K citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +16

Efficacy and safety of once-daily darunavir/ritonavir versus lopinavir/ritonavir in treatment-naive HIV-1-infected patients at week 48

Roberto Ortiz, Edwin DeJesus, Homayoon Khanlou et al. · AIDS · 2008 · 383 citations

Medicine, Pharmacology, Pharmacotherapy +17

TMC114, a Novel Human Immunodeficiency Virus Type 1 Protease Inhibitor Active against Protease Inhibitor-Resistant Viruses, Including a Broad Range of Clinical Isolates

Sandra De Meyer, Hilde Azijn, Dominique Surleraux et al. · Antimicrobial Agents and Chemotherapy · 2005 · 357 citations

Life Sciences, Infectious Diseases, Molecular Biology +17

Discovery and Selection of TMC114, a Next Generation HIV-1 Protease Inhibitor

Dominique Surleraux, Abdellah Tahri, Wim G. Verschueren et al. · Journal of Medicinal Chemistry · 2004 · 256 citations

Life Sciences, Medicinal Chemistry, Pharmacology +17

Short-Time Infusion of Fish Oil-Based Lipid Emulsions, Approved for Parenteral Nutrition, Reduces Monocyte Proinflammatory Cytokine Generation and Adhesive Interaction with Endothelium in Humans

Konstantin Mayer, Sandra De Meyer, Marion Reinholz-Muhly et al. · The Journal of Immunology · 2003 · 192 citations · Full text

Life Sciences, Immunology, Nutritional Sciences +17